マーケットレポート詳細
がん生検の世界市場：2031年予測
Cancer Biopsy Market (Product: Platforms & Instruments, Kits & Reagents, and Services; Type: Tissue Biopsies, Liquid Biopsies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
- 出版元：Transparency Market Research
出版元について - 発行年：2023年 5月
- 定価 ：Single User License(1名様ライセンス)US$5,795(米国ドル)/ Multi User License $8,795 / Corporate User License $11,795
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文190ページになります。
- 商品コード：TMR022
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
がん生検の世界市場規模は2022年で247億ドル、2031年に660億ドル、市場の平均年成長率は11.4%で拡大すると見込まれます。
当レポートでは、がん生検の市場予測-2031年、各種セグメント別市場分析(生検タイプ別、がん種類別、国地域別、等)、市場の機会、競合状況、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
■がん生検の世界市場予測2017-2031年
・市場規模(US$)
■製品別、市場-2031年
プラットフォーム、機器
キット、試薬
サービス
※(市場規模US$)
■生検タイプ別、市場-2031年
組織生検
・針生検
・外科的生検
リキッドバイオプシー（液体生検）
その他
※(市場規模US$)
■がん種類別、市場-2031年
乳がん
大腸がん
子宮頸がん
肺がん
前立腺がん
皮膚がん
血液がん
腎臓がん
肝臓がん
膵臓がん
卵巣がん
その他
※(市場規模US$)
■主要国地域別市場-2031年
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス、スペイン、イタリア
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
南米
・ブラジル、メキシコ
・その他南米
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
■市場分析
市場の促進要因、障壁、機会
技術的進化
市場シェア
競合状況
■がん生検の主要企業プロフィール動向
Abbott Laboratories
Becton, Dickinson and Company
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Illumina, Inc.
Siemens Healthineers
GE Healthcare
Bio-Rad Laboratories, Inc.
オリンパス株式会社
QIAGEN
（全190頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cancer Biopsy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cancer Biopsy Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Cancer Prevalence & Incidence, by Region
5.2. Technological Advancements
5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
5.4. Reimbursement Scenario by Region/Globally
5.5. Value Chain Analysis
6. Global Cancer Biopsy Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. Platforms & Instruments
6.3.2. Kits & Reagents
6.3.3. Services
6.4. Market Attractiveness Analysis, by Product
7. Global Cancer Biopsy Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type, 2017-2031
7.3.1. Tissue Biopsies
7.3.1.1. Needle Biopsies
7.3.1.2. Surgical Biopsies
7.3.2. Liquid Biopsies
7.3.3. Others
7.4. Market Attractiveness Analysis, by Type
8. Global Cancer Biopsy Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Breast Cancer
8.3.2. Colorectal Cancer
8.3.3. Cervical Cancer
8.3.4. Lung Cancer
8.3.5. Prostate Cancer
8.3.6. Skin Cancer
8.3.7. Blood Cancer
8.3.8. Kidney Cancer
8.3.9. Liver Cancer
8.3.10. Pancreatic Cancer
8.3.11. Ovarian Cancer
8.3.12. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Cancer Biopsy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Cancer Biopsy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. Platforms & Instruments
10.2.2. Kits & Reagents
10.2.3. Services
10.3. Market Value Forecast, by Type, 2017-2031
10.3.1. Tissue Biopsies
10.3.1.1. Needle Biopsies
10.3.1.2. Surgical Biopsies
10.3.2. Liquid Biopsies
10.3.3. Others
10.4. Market Value Forecast, by Application, 2017-2031
10.4.1. Breast Cancer
10.4.2. Colorectal Cancer
10.4.3. Cervical Cancer
10.4.4. Lung Cancer
10.4.5. Prostate Cancer
10.4.6. Skin Cancer
10.4.7. Blood Cancer
10.4.8. Kidney Cancer
10.4.9. Liver Cancer
10.4.10. Pancreatic Cancer
10.4.11. Ovarian Cancer
10.4.12. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Type
10.6.3. By Application
10.6.4. By Country
11. Europe Cancer Biopsy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. Platforms & Instruments
11.2.2. Kits & Reagents
11.2.3. Services
11.3. Market Value Forecast, by Type, 2017-2031
11.3.1. Tissue Biopsies
11.3.1.1. Needle Biopsies
11.3.1.2. Surgical Biopsies
11.3.2. Liquid Biopsies
11.3.3. Others
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Breast Cancer
11.4.2. Colorectal Cancer
11.4.3. Cervical Cancer
11.4.4. Lung Cancer
11.4.5. Prostate Cancer
11.4.6. Skin Cancer
11.4.7. Blood Cancer
11.4.8. Kidney Cancer
11.4.9. Liver Cancer
11.4.10. Pancreatic Cancer
11.4.11. Ovarian Cancer
11.4.12. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Type
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Cancer Biopsy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. Instruments
12.2.2. Kits & Reagents
12.2.3. Services
12.3. Market Value Forecast, by Type, 2017-2031
12.3.1. Tissue Biopsies
12.3.1.1. Needle Biopsies
12.3.1.2. Surgical Biopsies
12.3.2. Liquid Biopsies
12.3.3. Others
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Breast Cancer
12.4.2. Colorectal Cancer
12.4.3. Cervical Cancer
12.4.4. Lung Cancer
12.4.5. Prostate Cancer
12.4.6. Skin Cancer
12.4.7. Blood Cancer
12.4.8. Kidney Cancer
12.4.9. Liver Cancer
12.4.10. Pancreatic Cancer
12.4.11. Ovarian Cancer
12.4.12. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Type
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Cancer Biopsy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. Platforms & Platforms & Instruments
13.2.2. Kits & Reagents
13.2.3. Services
13.3. Market Value Forecast, by Type, 2017-2031
13.3.1. Tissue Biopsies
13.3.1.1. Needle Biopsies
13.3.1.2. Surgical Biopsies
13.3.2. Liquid Biopsies
13.3.3. Others
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Breast Cancer
13.4.2. Colorectal Cancer
13.4.3. Cervical Cancer
13.4.4. Lung Cancer
13.4.5. Prostate Cancer
13.4.6. Skin Cancer
13.4.7. Blood Cancer
13.4.8. Kidney Cancer
13.4.9. Liver Cancer
13.4.10. Pancreatic Cancer
13.4.11. Ovarian Cancer
13.4.12. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Type
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Cancer Biopsy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
14.2.1. Platforms & Instruments
14.2.2. Kits & Reagents
14.2.3. Services
14.3. Market Value Forecast, by Type, 2017-2031
14.3.1. Tissue Biopsies
14.3.1.1. Needle Biopsies
14.3.1.2. Surgical Biopsies
14.3.2. Liquid Biopsies
14.3.3. Others
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Breast Cancer
14.4.2. Colorectal Cancer
14.4.3. Cervical Cancer
14.4.4. Lung Cancer
14.4.5. Prostate Cancer
14.4.6. Skin Cancer
14.4.7. Blood Cancer
14.4.8. Kidney Cancer
14.4.9. Liver Cancer
14.4.10. Pancreatic Cancer
14.4.11. Ovarian Cancer
14.4.12. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Type
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Becton, Dickinson and Company
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. F. Hoffmann-La Roche Ltd.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Hologic, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Danaher Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Thermo Fisher Scientific, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Agilent Technologies, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Illumina, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Siemens Healthineers
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. GE Healthcare
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Bio-Rad Laboratories, Inc.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
15.3.12. Olympus Corporation
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
15.3.13. QIAGEN
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.13.5. Strategic Overview
List of Tables
Table 01: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 03: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 05: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 06: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 08: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 09: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 10: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 11: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 12: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 13: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 16: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 17: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 18: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 19: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 21: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 22: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 23: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 24: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 25: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 27: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 28: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 29: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 30: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
Table 31: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 33: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 34: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 35: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031
Table 36: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031
List of Figures
Figure 01: Global Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 02: Global Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 03: Global Cancer Biopsy Market Revenue (US$ Mn), by Platforms & Instruments, 2017-2031
Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Kits & Reagents, 2017-2031
Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Services, 2017-2031
Figure 05: Global Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 06: Global Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
Figure 07: Global Cancer Biopsy Market Revenue (US$ Mn), by Tissue Biopsies, 2017-2031
Figure 08: Global Cancer Biopsy Market Revenue (US$ Mn), by Liquid Biopsies, 2017-2031
Figure 09: Global Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 10: Global Cancer Biopsy Market Attractiveness Analysis, Application, 2023-2031
Figure 11: Global Cancer Biopsy Market Revenue (US$ Mn), by Breast Cancer, 2017-2031
Figure 12: Global Cancer Biopsy Market Revenue (US$ Mn), by Colorectal Cancer, 2017-2031
Figure 13: Global Cancer Biopsy Market Revenue (US$ Mn), by Cervical Cancer 2022 and 2031
Figure 14: Global Cancer Biopsy Market Revenue (US$ Mn), Lung Cancer, 2023-2031
Figure 15: Global Cancer Biopsy Market Revenue (US$ Mn), by Prostate Cancer, 2017-2031
Figure 16: Global Cancer Biopsy Market Revenue (US$ Mn), by Skin Cancer, 2017-2031
Figure 17: Global Cancer Biopsy Market Revenue (US$ Mn), by Blood Cancer, 2017-2031
Figure 18: Global Cancer Biopsy Market Revenue (US$ Mn), Kidney Cancer, 2023-2031
Figure 19: Global Cancer Biopsy Market Revenue (US$ Mn), by Liver Cancer, 2017-2031
Figure 20: Global Cancer Biopsy Market Revenue (US$ Mn), by Pancreatic Cancer, 2017-2031
Figure 21: Global Cancer Biopsy Market Revenue (US$ Mn), by Ovarian Cancer, 2017-2031
Figure 22: Global Cancer Biopsy Market Revenue (US$ Mn), by Others, 2017-2031
Figure 23: Global Cancer Biopsy Market Value Share Analysis, by Region, 2022 and 2031
Figure 24: Global Cancer Biopsy Market Attractiveness Analysis, by Region, 2023-2031
Figure 25: North America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 26: North America Cancer Biopsy Market Value Share Analysis, by Country, 2022 and 2031
Figure 27: North America Cancer Biopsy Market Attractiveness Analysis, by Country, 2023-2031
Figure 28: North America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 29: North America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 30: North America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 31: North America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
Figure 32: North America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 33: North America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 34: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 35: Europe Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Europe Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 37: Europe Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 38: Europe Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 39: Europe Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 40: Europe Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
Figure 41: Europe Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 42: Europe Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 43: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 44: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 45: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 46: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 47: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 48: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 49: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031
Figure 50: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 51: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 52: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 53: Latin America Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 54: Latin America Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 55: Latin America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 56: Latin America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 57: Latin America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 58: Latin America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
Figure 59: Latin America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 60: Latin America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 61: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031
Figure 62: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 63: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 64: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031
Figure 65: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031
Figure 66: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031
Figure 67: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031
Figure 68: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031
Figure 69: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031
Figure 70: Global Cancer Biopsy Market Share Analysis, by Company 2022